Mats-Olof Wallin

Financieel Directeur/CFO bij OxThera AB

73 jaar

Health Technology

Consumer Services

Actieve functies van Mats-Olof Wallin

Bedrijven	Functie	Begin	Einde
OxThera AB OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden.	Financieel Directeur/CFO	01-01-2020	-

Bedrijven	Functie	Begin	Einde
KARO PHARMA AB (PUBL)	Financieel Directeur/CFO	01-01-2018	01-10-2019
SWEDISH ORPHAN BIOVITRUM AB	Financieel Directeur/CFO	08-04-2013	20-07-2018
BIOTAGE AB	Financieel Directeur/CFO	17-05-2010	01-01-2012
BIOTAGE AB	Public Communications Contact	17-05-2010	01-01-2012

University of Uppsala

Undergraduate Degree

Internationaal

Zweden

Operationeel

Director of Finance/CFO	4
Public Communications Contact	1
Undergraduate Degree	1

Sectoraal

Health Technology	5
Consumer Services	2

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Bedrijven in privébezit	1
OxThera AB OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden.	Health Technology

Bedrijven in privébezit

Health Technology